Expression, purification and crystallization of human 5-lipoxygenase- activating protein with leukotriene-biosynthesis inhibitors

Acta Crystallographica Section F: Structural Biology and Crystallization Communications

Volumn 63, Issue 12, 2007, Pages 1054-1057

  Xu, Shihua ^a   McKeever, Brian M ^a,b   Wisniewski, Douglas ^a   Miller, Douglas K ^a,c   Spencer, Robert H ^a,d   Chu, Lin ^a   Ujjainwalla, Feroze ^a   Yamin, Ting Ting ^a   Evans, Jilly F ^a,e   Becker, Joseph W ^a   Ferguson, Andrew D ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b Vitae Pharmaceuticals   (United States)

^c PFIZER INC   (United States)

^d Cara Therapeutics   (United States)

^e Amira Pharmaceuticals   (United States)

Author keywords

5 lipoxygenase activating protein; Leukotriene synthesis; Membrane proteins

Indexed keywords

5-LIPOXYGENASE-ACTIVATING PROTEIN; ARACHIDONATE 5 LIPOXYGENASE ACTIVATING PROTEIN; CARRIER PROTEIN; LEUKOTRIENE; MEMBRANE PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BIOSYNTHESIS; CHEMICAL STRUCTURE; CHEMISTRY; CRYSTALLIZATION; GENE EXPRESSION; GENETICS; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; X RAY CRYSTALLOGRAPHY;

CARRIER PROTEINS; CRYSTALLIZATION; CRYSTALLOGRAPHY, X-RAY; GENE EXPRESSION; HUMANS; LEUKOTRIENES; MEMBRANE PROTEINS; MOLECULAR STRUCTURE;

ESCHERICHIA COLI;

EID: 36849083574     PISSN: 17443091     EISSN: 17443091     Source Type: Journal    
DOI: 10.1107/S1744309107055571     Document Type: Article

References (23)

1. Bresell, A., Weinander, R., Lundqvist, G., Raza, H., Shimoji, M., Sun, T., Balk, L., Wiklund, R., Eriksson, J., Jansson, C., Persson, B., Jakobsson, P. & Morgenstern, R. (2005). FEBS J. 272, 1688-1703.
2. Brideau, C. et al. (1992). Can. J. Physiol. Pharm. 70, 799-807.
3. Charleson, S., Prasit, P., Leger, S., Gillard, J., Vickers, P., Mancini, J., Charleson, P., Guay, J., Ford-Hutchinson, A. & Evans, J. (1992). Mol. Pharmacol. 41, 873-879.
4. Derewenda, Z. S. (2004). Structure, 12, 529-535.
5. Derewenda, Z. S. & Vekilov, P. G. (2006). Acta Cryst. D62, 116-124.
6. Dixon, R. A., Diehl, R. E., Opas, E., Rands, E., Vickers, P. J., Evans, J. F., Gillard, J. W. & Miller, D. K. (1990). Nature (London), 343, 282-284.
7. Doublié, S. (1997). Methods Enzymol. 276, 523-530.
8. Ferguson, A. D., McKeever, B. M., Xu, S., Wisniewski, D., Miller, D. K., Yamin, T. T., Spencer, R. H., Chu, L., Ujjainwalla, F., Cunningham, B. R., Evans, J. F. & Becker, J. W. (2007). Science, 317, 510-512.
9. Funk, C. D. (2001). Science, 294, 1871-1875.
10. Funk, C. D. (2005). Nature Rev. Drug Discov. 4, 664-672.
11. Lee, A. G. (2004). Biochim. Biophys. Acta, 1666, 62-87.
12. Mancini, J., Abramovitz, M., Cox, M., Wong, E., Charleson, S., Perrier, H., Wang, Z., Prasit, P. & Vickers, P. (1993). FEBS Lett. 318, 277-281.
13. Miller, D. K. et al. (1990). Nature (London), 343, 278-281.
14. Murphy, R. C. & Gijon, M. A. (2007). Biochem. J. 405, 379-395.
15. Otwinowski, Z. & Minor, W. (1997). Methods Enzymol. 276, 307-326.
16. Palsdottir, H. & Hunte, C. (2004). Biochim. Biophys. Acta, 1666, 2-18.
17. Plante, H., Picard, S., Mancini, J. & Borgeat, P. (2006). Biochem. J. 393, 211-218.
18. Prasit, P., Belley, M., Blouin, M., Brideau, C., Chan, C., Charleson, S., Evans, J., Frenette, R., Gauthier, J. & Guay, J. (1993). J. Lipid Mediat. 6, 239-244.
19. Radmark, O. & Samuelsson, B. (2005). Biochem. Biophys. Res. Commun. 338, 102-110.
20. Seddon, A. M., Curnow, P. & Booth, P. J. (2004). Biochim. Biophys. Acta, 1666, 105-117.
21. Vickers, P., Adam, M., Charleson, S., Coppolino, M., Evans, J. & Mancini, J. (1992). Mol. Pharmacol. 42, 94-102.
22. Young, R. (1999). Eur. J. Med. Chem. 34, 671-685.
23. Young, R., Gillard, J., Hutchinson, J., Leger, S. & Prasit, P. (1993). J. Lipid Mediat. 6, 233-238.